Curing All Disease with AI with Max Jaderberg

What It Covers

Max Jaderberg from Isomorphic Labs explains how AlphaFold AI predicts protein folding structures with experimental-level accuracy, revolutionizing drug discovery by reducing development costs from three billion dollars per drug while targeting cancer and immunology.

Key Questions Answered

• •AlphaFold Accuracy: AlphaFold three achieves experimental-level accuracy predicting three-dimensional protein structures from amino acid sequences, completing in minutes what previously required months of crystallization and X-ray scattering analysis by biochemists in laboratory settings.
• •Drug Development Economics: Traditional drug development costs three billion dollars per molecule using random screening of millions of compounds. AI-driven rational design narrows search space from ten to the sixtieth power possible molecules, dramatically reducing costs and development timelines.
• •Protein Folding Foundation: Proteins fold spontaneously into three-dimensional shapes that function as molecular machines. Their interactions depend on shape-fitting dynamics at microsecond timescales. Misfolding causes diseases, while correct folding enables cellular function through thousands of interacting atoms.
• •Clinical Translation Path: AlphaFold enables bespoke drug design targeting individual patient mutations, particularly for cancer treatment. Drugs must achieve multiple properties simultaneously: target specificity, solubility, cell permeability, and non-toxicity while reaching correct tissue locations through bloodstream delivery.